Status:
COMPLETED
Hostility Reduction Program to Improve Autonomic Regulation of the Heart
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Hostility
Coronary Arteriosclerosis
Eligibility:
All Genders
20-45 years
Phase:
NA
Brief Summary
Individuals who experience high hostility levels may be more prone to developing coronary artery disease (CAD) than individuals who experience low hostility levels. This study will evaluate the effect...
Detailed Description
CAD is caused by a narrowing of the blood vessels that supply blood and oxygen to the heart. It is the leading cause of death in the United States. Recent evidence has suggested that individuals with ...
Eligibility Criteria
Inclusion
- In good general health
- Experiences a high level of hostility according to the Spielberger Trait Anger Scale and Cook Medley Scale (greater than 1 standard deviation for each scale)
- English speaking
Exclusion
- Psychiatric disorder
- Currently taking psychiatric medications
- Currently taking cardioactive medications
- Medical condition that affects the ANS
- Currently taking medications that affect the cardiovascular system
Key Trial Info
Start Date :
December 1 1999
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00365196
Start Date
December 1 1999
End Date
January 1 2006
Last Update
February 18 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.